Early Remission Is a Realistic Target in a Majority of Patients with DMARD-naive Rheumatoid Arthritis. [electronic resource]
- The Journal of rheumatology Apr 2016
- 699-706 p. digital
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
1499-2752
10.3899/jrheum.141480 doi
Adult Aged Antirheumatic Agents--therapeutic use Arthritis, Rheumatoid--blood Autoantibodies--blood Female Humans Male Middle Aged Peptides, Cyclic--immunology Remission Induction--methods Rheumatoid Factor--blood Severity of Illness Index Treatment Outcome